Lifastuzumab Vedotin
Lifastuzumab Vedotin Uses, Dosage, Side Effects, Food Interaction and all others data.
Lifastuzumab Vedotin is under investigation in clinical trial NCT01363947 (Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer).
| Trade Name | Lifastuzumab Vedotin |
| Generic | Lifastuzumab vedotin |
| Lifastuzumab vedotin Other Names | DNIB0600A, Lifastuzumab vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lifastuzumab Vedotin
